During the course of experiments to explore and develop cyclization reactions of indolic systems, a number of unusual rearrangement reactions were discovered, and are reported in this paper. We describe routes to 4-substituted (methylsufanylmethyl)indole derivatives, and a simple route to a cyclopropanone derivative of a tetrahydro-β-carboline.
Introduction
There are an enormous number of important indolic natural products, containing a plethora of fused ring systems, as exemplified below ( Figure 1 ). Our interest has been in using tryptophan as the chiral starting material for the synthesis of such compounds, 2 and in developing synthetic methods for accessing the polycyclic structures. Our first set of indole analogues were simple acyl derivatives of tryptamine 8 and tryptophan methyl ester 9. We found that both of these reactions also proceeded with both cyclization and rearrangement, giving the 4-substituted products 10 and 11 in moderate yield, although the yield of the latter reaction was dramatically improved (to 95%) when the reaction was carried out in acetonitrile. 
Scheme 2
The tryptophan derivative might be especially useful; for example, reduction with Raney nickel should generate the 4-methyltryptophan derivative, whilst other 4-substituted derivatives should be accessible using sulfide/sulfoxide chemistry, for incorporation into peptides. We were therefore pleased that reductive ring-opening of the tryptamine derivative 10 took place essentially quantitatively, thereby confirming that the ring-opening/unmasking can be easily achieved.
We next explored the range of indolic substrates suitable for the Sommelet-Hauser rearangement ( Figure 2 ). Our choice was significantly guided by our proposed mechanism (see Scheme 3 below, and associated discussion), and we were therefore disappointed that only the three derivatives shown in Schemes 1 and 2 underwent the reaction. Substrates that failed to undergo the rearrangement.
Next we turned to the mechanism for this reaction, for which our proposal is shown in Scheme 3, in which a sulfonium intermediate is in equilibrium with an ylide, which can then undergo the Sommelet-Hauser rearrangement. When the reaction was carried out entirely at low temperature, then the expected cyclization took place without introduction of the MeSCH 2 group; similarly, using only one equivalent of the Swern reagent, but allowing the reaction to warm up, also led to the simple cyclization product; finally, replacing trifluoroacetic anhydride with oxalyl chloride 9 also led to cyclization without rearrangement. These results indicate that the [6.5.5] system must be pre-formed before the SommeletHauser rearrangement can occur (in these systems, at least). Crucially, the Sommelet-Hauser rearrangement requires de-aromatization of the 'pyrrolic' indole ring before the [2,3] sigmatropic shift can occur, and it is noteworthy that the sulfonium salt (Figure 2 , final entry) failed to undergo any reaction with triethylamine under our 'Swern' conditions. We had hoped that other heteroatoms tethered to the indole 3-position would be able to stabilise the key intermediates required for the Sommelet-Hauser rearrangement, but this turned out not to be the case. Although Swern et al have reported ortho-CH 2 SMe insertion in the oxidation of an aniline derivative, 7b our Swern-induced Sommelet-Hauser rearrangement for indolic systems has not been previously reported.
Section B. Cyclopropanone formation from a diazomethyl ketone
In work towards the [6.5.5.6] spiro system in ajmaline (3), we hoped to use a carbene insertion reaction, as outlined in Scheme 4. We prepared the model diazoketone as shown in Scheme 5. Thus, allyl ester 14 10 was benzylated, after which the trans specific Pictet-Spengler reaction 11 gave the tetrahydro-β-carboline 15. After N in -methylation, and palladium catalyzed deprotection of the ester, the diazoketone 19 was prepared via the mixed anhydride 18. Scheme 4. Planned route to key [6.5.6 .5] spiro ring system of ajmaline.
Intriguingly, reaction with rhodium II acetate generated the cyclopropanone 22 instead of the desired spiro system, as a single diastereoisomer, for which the IR stretch at 1805 cm -1 and 13 C peak at 205 ppm were indicative of the strained ketone. If the mechanism we propose in Scheme 5 is correct, then the trans product shown would be expected, via pseudo-axial attack on the iminium intermediate in which the phenyl group is axial.
3b As in the case of the Sommelet-Hauser rearrangement, the fine interplay of steric and electronic factors are probably prerequisites for the rearrangement/cyclization, involving hydride shift and subsequent ring closure. We are exploring the generality of this unusual reaction, and the possible synthetic utility of the resulting cyclopropanones.
Experimental Section
General Procedures. General procedures followed during the course of the work detailed herein were similar to those reported elsewhere.
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Synthetic studies Section A Preparation of brevianamide F (6) . 4d L-Proline methyl ester hydrochloride (1.39 g: 8.4 mmol) was dissolved in DMF (40 mL) and diisopropylethylamine (3 mL). To a DMF (60 mL) solution of N-Z-tryptophan (2.84 g: 8.4 mmol) and 1-hydroxybenzotriazole (1.25 g: 9.2 mmol) was added EDC (1.76 g: 9.2 mmol) in DMF (100 mL) at 0 ºC over 5 minutes. This was stirred at 0 ºC for 1 hour then at room temperature for half an hour. The DMF/DIPEA solution of L-proline was then added and the resultant solution stirred overnight. After this time the solvent was removed under vacuum and resultant oil dissolved in dichloromethane. This solution was washed with water (2 x 100 mL), saturated sodium bicarbonate solution (2 x 100 mL), citric acid solution (0.7 M: 2 x 100 mL) then water again before finally being dried over magnesium sulfate. The solution was filtered and the solvent removed under vacuum to give a crude white foam of the protected dipeptide Z-Trp-Pro-OMe (3.07 g: 80%) which was used in the next step without further purification. The dipeptide (3.07 g: 6.8 mmol) was dissolved in methanol (100 mL) then the solvent removed under vacuum. This process was repeated twice before finally the starting material was dissolved in methanol (150 mL). To this solution was added palladium catalyst (Degussa type: 0.5 g). The solution was flushed three times with hydrogen before being left to stir overnight under a hydrogen atmosphere. After this time, the catalyst was removed by filtration and the solvent removed in vacuo to give the crude product as a colourless oil. The crude material was purified by flash chromatography eluting with 1:1 ethyl acetate/dichloromethane to yield the desired product 6 as a white solid (1.77 g: 92%): R f 0. . To a solution of trifluoroacetic anhydride (566 µL: 4.0 mmol) in dichloromethane (20 mL) cooled to -78 ºC was added dimethylsulfoxide (568 µL: 8.0 mmol) in dichloromethane (2 mL). This solution was stirred at -78 ºC for 10 minutes before a solution of brevianamide F 6 (218.0 mg: 0.77 mmol) was added in dichloromethane (25 mL) via a canula. The reaction was stirred at -78 ºC for 1 hour before triethylamine (15 mL) was added. The reaction was stirred for a further 2.5 hours during which time it was allowed to warm to room temperature. At this time the reaction mixture was poured into a separating funnel containing brine (20 mL). The organic phase was collected and washed further with sodium hydrogencarbonate solution (2 x 20 mL) and brine (2 x 20 mL) before being collected and dried over CaC1 2 . Upon filtration and removal of the solvent, the crude material was obtained as a yellow coloured foam. This was purified by flash chromatography eluting with 4:6 ethyl acetate and dichloromethane. 
Methyl (3S)-1-acetyl-4-(methylsulfanylmethyl)-1,2,3,8-tetrahydropyrrolo[2,3-b]indole-2-carboxylate (11).
To a solution of trifluoroacetic anhydride (283 µL: 2.0 mmol) in dichloromethane (10 mL) cooled to -78 ºC was added dimethylsulfoxide (284 µL: 4.0 mmol) in dichloromethane (2 mL). This solution was stirred at -78 ºC for 10 minutes before a solution of N-acetyl tryptophan methyl ester (99.7 mg: 0.39 mmol) was added in dichloromethane (15 mL) via a canula. The reaction was stirred for 0.5 hours at -78 ºC before allowing the solution to warm to 0ºC over 2 hours. The reaction was then cooled back to -78 ºC before triethylamine (7 mL) was added. The reaction was stirred for a further 2.5 hours during which time it was allowed to warm to room temperature. At this time the reaction mixture was poured into a separating funnel containing brine (20 mL). The organic phase was collected and washed further with sodium hydrogencarbonate solution (2 x 20 mL) and brine (2 x 20 mL) before being collected and dried over CaC1 2 . Upon filtration and removal of the solvent, the crude material was obtained as a yellow foam. This was purified by flash chromatography eluting with 4:6 ethyl acetate/ dichloromethane, and the product 11 was isolated as a pale yellow coloured foam (55.7 mg: 45 %). Running the reaction on a 500 mg scale of Ac-Trp-OMe, but replacing dichloromethane by acetonitrile, gave 580 mg (95%) of the same product. R f 0.69 (1: 
Preparation of 4-(methylsulfanylmethyl)tryptamine (12)
. To a stirred suspension of 11 (21 mg, 80.3 mmol) in MeOH (5 ml) under nitrogen was added solid NaBH 3 CN (6 mg, 0.1 mmol) followed by 2-3 drops of dilute 2M HCl. The solid rapidly dissolved to form a yellow solution. The reaction was followed by TLC and after 1 h the reaction mixture was evaporated to dryness. The residue was taken back up into dichloromethane, washed with saturated NaHCO 3 (2x), brine, dried (MgSO 4 ) and evaporated to dryness to afford 22 mg (99 %) of the reduction product 12 as a clear oil. 
Section B L-Tryptophan allyl ester (14)
To L-tryptophan (15 g, 61 mmol) dissolved in allyl alcohol (150 ml), acetyl chloride was then added, and the resulting purple solution was maintained at reflux for 18 hr. It was then cooled to RT, and 10 % ammonia solution (250 ml) and CH 2 Cl 2 (150 ml) were added. The phases were separated and the aqueous extracted with CH 2 Cl 2 (2 x 250 ml). The combined organics were dried over MgSO 4 , filtered and solvent removed in vacuo. The product was purified by column chromatography using 50:50 CHC1 3 : diethyl ether, giving 6.02 g (26 %) of the white solid 14, which exhibited spectra in accordance with those already reported. 1 mmol) was dissolved in dry methanol (15 ml), benzaldehyde (460 µl, 4.5 mmol) was then added and the resultant solution was stirred at RT for 2 hr. The solution was then cooled to -30 ºC and sodium borohydride (77 mg, 2.1 mmol) was added portion-wise over 5 min. whilst maintaining the temperature at -30 ºC. The resultant mixture was then stirred at -30 ºC for 30 min, warmed to -10 ºC, AcOH (400 µl) was then added and the reaction mixture was warmed to RT. The solvent was removed in vacuo, the residue redissolved in CH 2 Cl 2 (15 ml) and benzaldehyde (460 µl, 4.5 mmol) added. The resultant solution was then heated to reflux for 18 hr, cooled to RT and the solvent removed in vacuo. The product 15 was purified by column chromatography 3:2 CH 2 C1 2 : hexane, to give 904 mg (54 %) of a colourless oil: ν max /cm -1 (neat) 3405, 3084, 3060, 3027, 2945, 2918, 2851, 1728, 1600, 1493, 1454, 1371, 1357, 1323, 1302, 1270, 1217, 1178, 1140, 1091, 1075, 1028, 1010, 971, 926, 747 4, 142.8, 140.0, 137.1, 135.5, 132.6, 129.5, 129.3, 129.2, 129.0, 128.6, 127.7, 127.5, 122.2, 120.0, 118.8, 118.5, 111.5, 106.9, 65.4, 61.4, 56.7, 54.9, 25.0; HRMS (electrospray) 
Allyl (1R,3S)-9-methyl-1-phenyl-2-(phenylmethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (16).
The allyl ester 15 (571 mg, 1.35 mmol) dissolved in dry DMF (15 ml) and cooled to 0 ºC. NaH (54 mg of a 60 % dispersion in mineral oil, 1.35 mmol) and iodomethane (92 µl, 1.48 mmol) were added and the resultant mixture stirred at 0 ºC for 2 hr and RT for 2 hr. The solvent was removed in vacuo, the residue redissolved in CH 2 Cl 2 (15 ml) and washed with saturated sodium bicarbonate solution (30 ml). The phases were separated and the aqueous was washed with CH 2 Cl 2 (2 x 15 ml). The combined organics were dried over MgSO 4 , filtered and solvent removed in vacuo. The product was purified by column chromatography using 3:2 CH 2 C1 2 : hexane, to give 409 mg (69 %) of a colourless oil. The product 16 displayed the following 1 H NMR data, but was used without further characterisation: ν max /cm -1 (neat) 3057, 3027, 2933 , 2847 , 1732 , 1647 , 1492 , 1470 , 1454 , 1372 , 1262 , 1216 , 1172 δH (400 MHz, CDCl 2, 142.0, 140.2, 137.9, 135.4, 132.6, 129.9, 129.4, 128.8, 128.7, 128.1, 127.6, 126.9, 121.7, 119.5, 118.8, 118.5, 109.3, 107.5, 65.5, 59.9, 56.5, 53.7, 30.4, 23.5; HRMS (electrospray) 
